Luster et al. from the University of Wurzburg (Germany) in the March issue of Endocrine-
Related Cancer (2005; 12: 49–64) presented a comprehensive international review of …

Traditionally, withdrawal of thyroid hormone has been used to attain the increase in serum
TSH concentrations that are believed to optimize the trapping and retention of radioiodine …

We investigated whether recombinant human TSH (rhTSH) safely and effectively induces
uptake of high-dose 131-iodine (131 I) to ablate thyroid remnant or treat disease, in patients …

Iodine-131 (I-131) ablation of thyroid remnant and/or persistent, recurrent or metastatic
tumour is part of the initial and subsequent management of well-differentiated thyroid …

We sought to evaluate the efficacy, biochemical effects, safety and outcome of recombinant
human thyroid-stimulating hormone (rhTSH) as an adjunct to radioiodine treatment of …

Objective To describe the use of recombinant human thyrotropin (thyroid-stimulating
hormone)(rhTSH) to assist in radioiodine therapy in a patient with thyroid carcinoma who …

Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for
preparation of thyroid remnant ablation with radioactive iodine (RAI) in low risk patients with …

-273-rhTSH 전처치한 후 지속암 혹은 재발암을 치료하였을때, rhTSH 는 기능성 종양 병변을
가진 거의 전 환자에서 방사성 요오드의 섭취를 촉진시키는 것으로 나타났다. rhTSH …

Full text: A serum TSH level of> 30 mU/L, which is necessary for reliable testing and efficient
radioiodine therapy in patients with differentiated thyroid carcinoma, may be achieved by: a …

Objective This study tested the hypothesis that administration of human recombinant thyroid-
stimulating hormone (rhTSH: Thyrogen, thyrotropin alpha) could promote iodine-131 ((131) …